- Home
- MREO vs BTMD Comparison
MREO vs BTMD Comparison
Compare MREO & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | BTMD |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 64.4M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MREO | BTMD |
|---|---|---|
| Price | $0.35 | $1.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $3.13 | $2.25 |
| AVG Volume (30 Days) | ★ 1.5M | 218.0K |
| Earning Date | 03-19-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.67 | ★ 722.22 |
| EPS | N/A | ★ 0.74 |
| Revenue | $500,000.00 | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $6,363.05 | $6.58 |
| P/E Ratio | ★ N/A | $1.95 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $1.35 |
| 52 Week High | $2.94 | $4.75 |
Technical Indicators
Market Signals| Indicator | MREO | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 29.31 |
| Support Level | $0.20 | N/A |
| Resistance Level | $0.42 | $2.79 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 22.62 | 17.47 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.